Long-term complications of COVID-19
AD Desai, M Lavelle… - American Journal of …, 2022 - journals.physiology.org
SARS-CoV-2 has rapidly spread across the globe and infected hundreds of millions of
people worldwide. As our experience with this virus continues to grow, our understanding of …
people worldwide. As our experience with this virus continues to grow, our understanding of …
COVID-19 and cardiovascular disease: from bench to bedside
A pandemic of historic impact, coronavirus disease 2019 (COVID-19) has potential
consequences on the cardiovascular health of millions of people who survive infection …
consequences on the cardiovascular health of millions of people who survive infection …
Extracorporeal membrane oxygenation for COVID-19: updated 2021 guidelines from the extracorporeal life support organization
J Badulak, MV Antonini, CM Stead… - Asaio …, 2021 - journals.lww.com
Disclaimer: This is an updated guideline from the Extracorporeal Life Support Organization
(ELSO) for the role of extracorporeal membrane oxygenation (ECMO) for patients with …
(ELSO) for the role of extracorporeal membrane oxygenation (ECMO) for patients with …
[HTML][HTML] Reaction of human monoclonal antibodies to SARS-CoV-2 proteins with tissue antigens: implications for autoimmune diseases
A Vojdani, E Vojdani, D Kharrazian - Frontiers in Immunology, 2021 - frontiersin.org
We sought to determine whether immune reactivity occurs between anti-SARS-CoV-2
protein antibodies and human tissue antigens, and whether molecular mimicry between …
protein antibodies and human tissue antigens, and whether molecular mimicry between …
Thrombosis in COVID‐19
Thrombotic complications are frequent in COVID‐19 and contribute significantly to mortality
and morbidity. We review several mechanisms of hypercoagulability in sepsis that may be …
and morbidity. We review several mechanisms of hypercoagulability in sepsis that may be …
COVID-19: specific and non-specific clinical manifestations and symptoms: the current state of knowledge
J Baj, H Karakuła-Juchnowicz, G Teresiński… - Journal of clinical …, 2020 - mdpi.com
Coronavirus disease 2019 (COVID-19), due to the severe acute respiratory syndrome
coronavirus-2 (SARS-CoV-2), has become an epidemiological threat and a worldwide …
coronavirus-2 (SARS-CoV-2), has become an epidemiological threat and a worldwide …
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): a systemic infection
A Synowiec, A Szczepański… - Clinical microbiology …, 2021 - Am Soc Microbiol
To date, seven identified coronaviruses (CoVs) have been found to infect humans; of these,
three highly pathogenic variants have emerged in the 21st century. The newest member of …
three highly pathogenic variants have emerged in the 21st century. The newest member of …
COVID-19: pulmonary and extra pulmonary manifestations
IH Elrobaa, KJ New - Frontiers in public health, 2021 - frontiersin.org
Introduction: The coronavirus disease-2019 (COVID-19) pandemic has been the most
significant event in 2020, with~ 86.8 million cases and 1.88 million deaths worldwide. It is a …
significant event in 2020, with~ 86.8 million cases and 1.88 million deaths worldwide. It is a …
European Resuscitation Council COVID-19 guidelines executive summary
JP Nolan, KG Monsieurs, L Bossaert, BW Böttiger… - Resuscitation, 2020 - Elsevier
Abstract Coronavirus disease 2019 (COVID-19) has had a substantial impact on the
incidence of cardiac arrest and survival. The challenge is to find the correct balance …
incidence of cardiac arrest and survival. The challenge is to find the correct balance …
An overview on the seven pathogenic human coronaviruses
To date, seven human coronaviruses (HCoVs) have been detected: HCoV‐NL63, HCoV‐
229E, HCoV‐HKU1, HCoV‐OC43, severe acute respiratory syndrome coronavirus (SARS …
229E, HCoV‐HKU1, HCoV‐OC43, severe acute respiratory syndrome coronavirus (SARS …